Christopher D. Cox

4.2k total citations
66 papers, 2.6k citations indexed

About

Christopher D. Cox is a scholar working on Molecular Biology, Organic Chemistry and Cognitive Neuroscience. According to data from OpenAlex, Christopher D. Cox has authored 66 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 26 papers in Organic Chemistry and 11 papers in Cognitive Neuroscience. Recurrent topics in Christopher D. Cox's work include Synthetic Organic Chemistry Methods (12 papers), Sleep and Wakefulness Research (9 papers) and Asymmetric Synthesis and Catalysis (8 papers). Christopher D. Cox is often cited by papers focused on Synthetic Organic Chemistry Methods (12 papers), Sleep and Wakefulness Research (9 papers) and Asymmetric Synthesis and Catalysis (8 papers). Christopher D. Cox collaborates with scholars based in United States and Belgium. Christopher D. Cox's co-authors include Thomas Lectka, Dana Ferraris, Paul J. Coleman, William J. Drury, Samuel J. Danishefsky, Brandon Young, Michael J. Breslin, John J. Renger, Anthony J. Roecker and Travis Dudding and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Accounts of Chemical Research.

In The Last Decade

Christopher D. Cox

66 papers receiving 2.6k citations

Peers

Countries citing papers authored by Christopher D. Cox

Since Specialization

Citations

This map shows the geographic impact of Christopher D. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Cox more than expected).

Fields of papers citing papers by Christopher D. Cox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Cox. The network helps show where Christopher D. Cox may publish in the future.

Co-authorship network of co-authors of Christopher D. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Cox. A scholar is included among the top collaborators of Christopher D. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Cox. Christopher D. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical evaluation of MK-8189: A novel phosphodiesterase 10A inhibitor for the treatment of schizophrenia 2024 ·Journal of Pharmacology and Experimental Therapeutics ·Sean M. Smith, Dawn Toolan, Monika Kandebo, Joshua D. Vardigan, Izzat T. Raheem, M. E. Layton, Jeffrey C. Kern, Christopher D. Cox, Liza Gantert, Kerry Riffel, Eric D. Hostetler, Jason M. Uslaner	1
2	Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia 2023 ·Journal of Medicinal Chemistry ·M. E. Layton, Jeffrey C. Kern, (unknown), William D. Shipe, Izzat T. Raheem, Monika Kandebo, Robert P. Hayes, Sarah L. Huszar, Donnie Eddins, Bennett Ma, (unknown), Gordon K. Wollenberg, Jing Li, (unknown), Georgia B. McGaughey, Jason M. Uslaner, Sean M. Smith, Paul J. Coleman, Christopher D. Cox	22
3	Stem Cell‐based therapies for COVID‐19‐related acute respiratory distress syndrome 2022 ·Journal of Cellular and Molecular Medicine ·(unknown), (unknown), Mohamed Hammad, Margarita Gutova, Karen S. Aboody, Christopher D. Cox	1
4	P300-tracking of changes in information processing / working memory in preclinical alzheimer’s and mild cognitive impairments (MCI) 2020 ·(unknown), Christopher D. Cox, (unknown), Jonathan R. T. Lakey, (unknown)	1
5	SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation 2019 ·Journal of Neuro-Oncology ·Fei Liu, Christopher D. Cox, Reshmi Chowdhury, (unknown), (unknown), Tie Li, Sichen Li, (unknown), Arthur P. Chou, (unknown), Bowen Wei, Joseph Antonios, Horacio Soto, Harley I. Kornblum, Linda M. Liau, Robert M. Prins, Phioanh L. Nghiemphu, William H. Yong, Timothy F. Cloughesy, Albert Lai	6
6	Overview of current diagnostic, prognostic, and therapeutic use of EEG and EEG-based markers of cognition, mental, and brain health 2019 ·Integrative Molecular Medicine ·(unknown), Christopher D. Cox, Michael P. Alexander, (unknown), Jonathan R. T. Lakey	5
7	D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant–Induced MIR148A Promoter Methylation 2018 ·Molecular Cancer Research ·(unknown), Christopher D. Cox, (unknown), (unknown), (unknown), (unknown), Sichen Li, Fei Liu, Harley I. Kornblum, Linda M. Liau, Phioanh L. Nghiemphu, Timothy F. Cloughesy, Albert Lai	8
8	Elevating microRNA-122 in blood improves outcomes after temporary middle cerebral artery occlusion in rats 2015 ·Journal of Cerebral Blood Flow & Metabolism ·Da Zhi Liu, Glen C. Jickling, Bradley P. Ander, Heather Hull, Xinhua Zhan, Christopher D. Cox, Natasha Shroff, Cheryl Dykstra-Aiello, Boryana Stamova, Frank R. Sharp	75
9	Myelin Injury and Degraded Myelin Vesicles in Alzheimer’s Disease 2014 ·Current Alzheimer Research ·Xinhua Zhan, Glen C. Jickling, Bradley P. Ander, Dazhi Liu, Boryana Stamova, Christopher D. Cox, (unknown), Charles DeCarli, Frank R. Sharp	62
10	The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey 2012 ·Neuropharmacology ·Sean M. Smith, Jason M. Uslaner, Christopher D. Cox, Sarah L. Huszar, Christopher E. Cannon, Joshua D. Vardigan, Donnie Eddins, Dawn Toolan, Monika Kandebo, Lihang Yao, Izzat T. Raheem, John D. Schreier, Michael J. Breslin, Paul J. Coleman, John J. Renger	70
11	Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia 2011 ·Neuropharmacology ·Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, Pamela L. Tannenbaum, Susan L. Garson, Scott M. Doran, Michael J. Breslin, John D. Schreier, Steven V. Fox, C. Meacham Harrell, Joanne Stevens, Duane R. Reiss, Donghui Cui, Paul J. Coleman, John J. Renger	109
12	Discovery of Allosteric Inhibitors of Kinesin Spindle Protein (KSP) for the Treatment of Taxane-Refractory Cancer: MK-0731 and Analogs 2010 ·Anti-Cancer Agents in Medicinal Chemistry ·Christopher D. Cox, R. M. Garbaccio	11
13	Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Paul J. Coleman, John D. Schreier, Georgia B. McGaughey, Michael J. Bogusky, Christopher D. Cox, George D. Hartman, Richard G. Ball, C. Meacham Harrell, Duane R. Reiss, Thomayant Prueksaritanont, Christopher J. Winrow, John J. Renger	12
14	Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat 2010 ·Bioorganic & Medicinal Chemistry Letters ·Paul J. Coleman, John D. Schreier, Anthony J. Roecker, Swati P. Mercer, Georgia B. McGaughey, Christopher D. Cox, George D. Hartman, C. Meacham Harrell, Duane R. Reiss, Scott M. Doran, Susan L. Garson, Wayne B. Anderson, Cuyue Tang, Thomayant Prueksaritanont, Christopher J. Winrow, John J. Renger	21
15	Kinesin spindle protein (KSP) inhibitors. Part V: Discovery of 2-propylamino-2,4-diaryl-2,5-dihydropyrroles as potent, water-soluble KSP inhibitors, and modulation of their basicity by β-fluorination to overcome cellular efflux by P-glycoprotein 2007 ·Bioorganic & Medicinal Chemistry Letters ·Christopher D. Cox, Michael J. Breslin, David B. Whitman, Paul J. Coleman, R. M. Garbaccio, Mark E. Fraley, Matthew M. Zrada, Carolyn A. Buser, Eileen S. Walsh, Kelly Hamilton, Robert B. Lobell, Weikang Tao, Marc Abrams, Vicki J. South, Hans E. Huber, Nancy E. Kohl, George D. Hartman	39
16	The Prevalence of Alzheimer Neuropathologic Lesions Is Similar in Blacks and Whites 2006 ·Journal of Neuropathology & Experimental Neurology ·Miguel A. Riudavets, Ana Rubio, Christopher D. Cox, Gay Rudow, David R. Fowler, Juan C. Troncoso	29
17	Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP 2005 ·Bioorganic & Medicinal Chemistry Letters ·Christopher D. Cox, Michael J. Breslin, (unknown), Paul J. Coleman, Carolyn A. Buser, Eileen S. Walsh, Kelly Hamilton, Hans E. Huber, Nancy E. Kohl, Maricel Torrent, Youwei Yan, (unknown), George D. Hartman	118
18	Studies Directed toward the Total Synthesis of Lactonamycin: Control of the Sense of Cycloaddition of a Quinone through Directed Intramolecular Catalysis 2003 ·Angewandte Chemie International Edition ·Christopher D. Cox, Tony Siu, Samuel J. Danishefsky	36
19	Total Synthesis of Lactonamycinone 2003 ·Angewandte Chemie International Edition ·Tony Siu, Christopher D. Cox, Samuel J. Danishefsky	36
20	Strong Hydrogen Bonding to the Amide Nitrogen Atom in an “Amide Proton Sponge”: Consequences for Structure and Reactivity 1999 ·Angewandte Chemie International Edition ·Christopher D. Cox, Harald Wack, Thomas Lectka	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact